Dr. Vijay Ramani

Post-Doctoral Fellow
UT Southwestern Medical Center, USA


Highest Degree
Ph.D. in Pharmacy from University of Oklahoma, USA

Share this Profile

Area of Interest:

Pharmacology and Toxicology
Pharmaceutical Analysis
Immunology
Pharmacy
Toxicological Research

Selected Publications

  1. Awasthi, S., B. Singh, V. Ramani, V. Awasthi, J. Xie and S. Kosanke, 2016. TLR4-interacting SPA4 peptide improves host defense in a mouse model of Pseudomonas aeruginosa lung infection. Nat. Mucosal Immunol., .

  2. Ramani, V and S. Awasthi, 2015. Toll-like receptor 4-interacting SPA4 peptide suppresses the NLRP3 inflammasome in response to LPS and ATP stimuli. J. Leukoc Biol., 98: 1037-1048.
    CrossRef  |  Direct Link  |  

  3. Ramani. V., R. Madhusoodhanan, S. Kosanke and S. Awasthi, 2013. A TLR4-interacting SPA4 peptide inhibits the lipopolysaccharide-induced lung inflammation. Innate Immun., 19: 596-610.
    CrossRef  |  Direct Link  |  

  4. Madhusoodhanan, R., C. Moriasi, V. Ramani, S. Anant and S. Awasthi, 2012. A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells. Oncoimmun., 1: 1495-1506.
    CrossRef  |  Direct Link  |  

  5. Langer, M., E.S. Duggan, J. Booth, V. Patel and V. Ramani et al., 2012. Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function. Infect. Immun., 80: 4374-4387.
    CrossRef  |  Direct Link  |  

  6. Manjula, S.N., N.N. Malleshappa, P.K. Vipan, M. Reddy and V. Ramani et al., 2009. Synthesis and antitumor activity of optically active thiourea and their 2 - aminobenzothiazole derivatives: A novel class of anticancer agents. Eur. J. Med. Chem., 44: 2923-2929.
    CrossRef  |  Direct Link  |